Every few years, a pathogen finds a population unprepared, and the resulting collision reveals how thin the margin between resilience and crisis truly is. New Zealand is living through such a moment: an influenza strain that evolved beyond the reach of existing immunity has driven Auckland's severe respiratory illness rates to their highest point in fourteen years, compounding an already burdened healthcare system. The strain itself is not unusually lethal, but its novelty is its power — a population without memory of it has little to offer in defense. In this, the current surge is less a stor
Flu drives respiratory illness to decade high as new A/H3 strain spreads
Severe respiratory illness surge strains ambulance services and emergency departments, with vulnerable populations at elevated risk of severe outcomes.
The virus found a door that was left unlocked
Mark
Why is this particular flu strain spreading so much faster than others we've seen recently?
Mimi
It's evolved enough that our bodies don't recognize it. Most people have immunity built up from previous flu seasons, but this A/H3 subclade K is different enough that those defenses don't work as well. It's like the virus found a door that was left unlocked.
Mark
But the vaccine was updated to match it. So why are we still seeing such high numbers?
Mimi
Because vaccines don't stop everyone from getting sick—they stop people from getting very sick. If you're vaccinated and you catch it, you might have mild symptoms. But not everyone is vaccinated, and vaccination rates are never 100 percent. With this many people vulnerable, the virus spreads fast through the population.
Mark
Is this strain actually more dangerous to individuals, or is it just the volume of cases?
Mimi
It's the volume. In the Northern Hemisphere, where it circulated first, there was no evidence it caused worse disease in any single person. But because so many people got infected at once, the overall burden on hospitals was severe. That's what we're seeing here now.
Mark
What does it mean that RSV and rhinovirus are also high right now?
Mimi
It means the respiratory illness system is under stress from multiple directions at once. It's not just flu season—it's several viruses circulating simultaneously. That compounds the pressure on ambulances and emergency departments.
Mark
Who should be most concerned about getting vaccinated?
Mimi
Older people and anyone with chronic health conditions. Those are the groups most likely to end up seriously ill or in the hospital. That's why the vaccine is funded for them. But it's not too late in the season to get one.
El Pulso
- Auckland's severe acute respiratory illness rates have reached their highest recorded levels since tracking began in 2012, with influenza A/H3 subclade K driving the surge alongside elevated RSV and rhinovirus activity.
- The strain's danger lies not in its severity but in its novelty — having evolved significantly from recent A/H3 variants, it encounters a population with almost no natural immunity to slow its spread.
- Ambulance services are struggling to meet demand and emergency departments are overflowing, prompting health authorities to publicly ask people to reserve emergency care for genuine emergencies.
- Updated flu vaccines do match the circulating strains, offering meaningful protection against severe illness and death for those who receive them — but vaccination rates remain incomplete.
- Health officials are urgently directing at-risk groups — older people and those with underlying conditions — to get vaccinated while the window remains open, as the system braces for continued pressure.
Every few years, a pathogen finds a population unprepared, and the resulting collision reveals how thin the margin between resilience and crisis truly is. New Zealand is living through such a moment: an influenza strain that evolved beyond the reach of existing immunity has driven Auckland's severe respiratory illness rates to their highest point in fourteen years, compounding an already burdened healthcare system. The strain itself is not unusually lethal, but its novelty is its power — a population without memory of it has little to offer in defense. In this, the current surge is less a story of a dangerous virus than of the perpetual negotiation between human immunity and a world of ceaselessly changing pathogens.
Auckland's hospitals and ambulance services are under extraordinary strain. Severe respiratory illness rates have climbed to their highest point in fourteen years, driven by an influenza strain that has found a population with almost no built-in defense against it. Alongside the flu, elevated rates of RSV and rhinovirus are compounding the pressure, while COVID-19 remains at very low levels.
The strain at the centre of the surge is influenza A/H3 subclade K, a variant that recently drove a severe flu season in the Northern Hemisphere. Its particular danger is not that it causes worse disease in individual patients — evidence suggests it does not — but that it spreads with unusual efficiency through a population that has never encountered it before. That absence of population-level immunity is what is fuelling its rapid transmission across New Zealand.
There is a measure of good news. Health authorities anticipated the strain's arrival and updated the Southern Hemisphere flu vaccine to match it closely, and laboratory testing confirms the alignment is good. For those who receive it, protection against severe illness and death is substantially improved. But vaccination cannot stop the spread entirely, and not everyone has received it — which is why officials are urgently urging at-risk groups, particularly older people and those with underlying health conditions, to get vaccinated while the opportunity remains.
The human cost of the surge is already visible. Ambulance services are struggling to keep pace with demand, and emergency departments are overwhelmed. Health authorities have begun asking the public to reserve emergency care for genuine emergencies — a telling signal of how close the system is to its limits.
Auckland's hospitals and ambulance services are running at a breaking point. Severe respiratory illness rates have climbed to their highest level in fourteen years, and the culprit is clear: a new strain of influenza that has found a population with almost no built-in defense against it.
The numbers tell the story. Since health officials began tracking severe acute respiratory illness in 2012, they have never recorded rates as high as what Auckland is experiencing right now. The surge is being driven primarily by influenza, with cases approaching the levels seen during the particularly bad 2022 season. But this year carries an additional burden. Alongside the flu, rates of respiratory syncytial virus and rhinovirus are also elevated, creating a compounding pressure on a healthcare system already stretched thin. COVID-19, by contrast, remains at very low levels of circulation.
The particular strain causing the current wave is influenza A/H3 subclade K. This variant emerged recently in the Northern Hemisphere, where it drove a severe flu season of its own. What makes it especially dangerous is not that it causes worse disease in individual patients—evidence from the Northern Hemisphere suggests it does not—but rather that it spreads with unusual efficiency. The strain has evolved significantly from other A/H3 variants that have circulated in recent years, meaning most people in New Zealand have no natural immunity built up from previous infections. That lack of population-level protection is the engine driving its rapid transmission.
There is one piece of good news in this picture. Health authorities anticipated this strain's arrival and updated the flu vaccine ahead of the Southern Hemisphere winter season to match it more closely. Laboratory data from New Zealand's Public Health and Wellbeing Science virology team confirms that the vaccines currently available do align well with the strains actually circulating. For people who receive the vaccine, protection against severe illness and death is substantially improved.
But vaccination alone cannot stop the spread. Not everyone gets vaccinated, and even vaccinated people can still contract influenza—the vaccine's primary purpose is to prevent the worst outcomes, not to prevent infection entirely. This is why New Zealand funds flu vaccination specifically for groups at highest risk: older people and those with underlying health conditions that make them vulnerable to severe complications. The window to get vaccinated this year remains open, and health officials are urging people to take it, particularly those in at-risk categories.
Meanwhile, the pressure on emergency services is mounting visibly. Ambulance services are struggling to keep up with demand, and emergency departments are overflowing with patients. Health authorities have begun asking the public to use emergency departments only for genuine emergencies, a sign of how strained the system has become. The surge in respiratory illness is not just a statistic—it is a direct strain on the people and infrastructure meant to care for the sickest and most vulnerable.
Citas Notables
The vaccine was updated ahead of the Southern Hemisphere season to better match influenza A/H3 subclade K, and laboratory data indicates the circulating strains do match the vaccine.— Public health expert
Even with a well-matched vaccine, influenza can spread rapidly through a population as not everyone is vaccinated, and vaccination does not prevent all influenza infections.— Public health expert
Quieres la nota completa?
Lee el original en Science Media Centre ↗
Health & Medicine